Search
Biontech SE
BNTXAdd to Watchlist
99.080USD
+0.560+0.57%
Close 09-25 16:00（ET）
25.06BMarket Cap
LossP/E TTM
After-hours 17:53 (ET)100.920USD+1.640+1.65%
After-hours 17:53 (ET)Biontech SE (BNTX) Stock Price Target & Forecast
Analyst Rating
Based on 22 analysts giving stock ratings to Biontech SE in the past month.
Buy
4 Strong Buy
13 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
124.100USD+25.96%
BNTX Analyst Recommendation Trends
In the current month, BNTX has received 13 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. BNTX average Analyst price target in the last month is 124.100.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
4
4
5
5
5
5
13
13
12
12
13
14
12
12
5
5
4
5
4
3
4
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
22
20
21
22
22
21
22
BNTX Analyst Rating for Peer Comparison
Updated: Sep 28, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
IQVIA Holdings Inc
IQV
7
12
6
0
0
25
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, BNTX EPS is projected to reach 0.976 in FY2026Q3, following reported EPS of -3.700 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.21
-2.53
-2.38
0.98
-1.55
Actual
-1.47
-2.43
-3.70
--
--
Surprise
-592.93%
+4.20%
-55.36%
--
--
FAQs
What is Biontech SE's expected revenue for the next quarter?
Biontech SE's expected revenue is 1.21B.
What is Biontech SE's price target?
Analysts forecast that Biontech SE's price target is USD 124.10, with the highest forecast at USD 181.00 and the lowest forecast at USD 85.00.
How have Biontech SEBNTX's recent earnings per share performed?
The market expectation was USD -3.70, while Biontech SEBNTX's earnings per share (EPS) for the previous quarter was USD -2.43. EPS for the next quarter is expected at USD 0.98.
What is the analyst rating for Biontech SE?
Based on the ratings of Biontech SE's stock from 22 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.